www.trustedtabs.net

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Ropinirole - Requip

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Requip

Generic Requip

Ropinirole 0.25/0.5/1/2mg

Generic Requip is used for treating Parkinson disease and restless leg syndrome (RLS).
More info »

$ 0.67 Buy now!
Country, language and currency
Social bookmarks:
Testimonials

Just wanted to write and say that I'm VERY satisfied with my purchase. I was skeptical at first, the price seemed too good and the shipping process too convoluted. But I sucked it up and took the plunge, ordered 90 of the lil blue guys and sat back to wait for packages that might never come. Happily I was SO wrong! 9 days after my order was placed I received my first batch of 30+4, and just today (another week later) I received the remaining 60. The quality of the product is outstanding. If you\'re sitting there, wondering whether or not you should go ahead and make a purchase here, quit wondering! The best prices, excellent service, and a top-notch product are all present here. Go for it!

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended ... - MarketWatch (press release)

    Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended .

  • Actavis wins FDA approval for Ropinirole extended-release tablets - Pharmaceutical Business Review

    Actavis wins FDA approval for Ropinirole extended-release tabletsPharmaceutical Business ReviewActavis Group, a generic pharmaceuticals company, has gained FDA approval for Ropinirole extended-release tablets, 2mg, 4mg, 6mg, 8mg and 12mg.

  • Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip - The Pharma Letter

    Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic RequipThe Pharma LetterSeparately, Switzerland headquartered Actavis Group, which is currently the subject of a 4.

  • NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights - MarketWatch (press release)

    NuPathe Announces First Quarter 2012 Financial Results and Operational HighlightsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery.

  • 아닌 밤중 '움찔움찔' 이유 있는 불면 - 충청투데이

    충청투데이아닌 밤중 '움찔움찔' 이유 있는 불면충청투데이대표적인 약물치료로는 도파민 전구물질제 투여와 도파민수용체효현제인 로피니롤(Ropinirole), 프라미펙솔(Pramipexole), 벤조디아제핀계약인 클로나제팜, 항경련제인 가바펜틴 등의 약을 사용한다.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.